International Companies

Mallinckrodt and Endo to merge in $6.7bn deal

By Michele Maatouk

Date: Thursday 13 Mar 2025

(Sharecast News) - Pharmaceutical firm Mallinckrodt said on Thursday that it has agreed to merge with Endo in a $6.7bn deal.
Under the terms of the agreement, Endo shareholders will receive $80m in cash and will own 49.9% of the combined company on a pro forma basis, while Mallinckrodt shareholders will...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page